Home » Topics » BioWorld Asia

BioWorld Asia
RSS

Thallia Aims For FFr90M, Enters Rowett Collaboration

April 14, 1999

Research Into Peg3 Gene Sheds Light On Imprinting

April 14, 1999

Xenova Sells Discovery Arm To TerraGen Diversity For #5M

April 14, 1999

CAT, Wyeth-Ayerst Enter $70M Genomics Agreement

April 7, 1999

Clal Biotechnology Commits $100M To Bolster Industry

April 7, 1999

Medica Holdings IPO Gets A$8M For Still More Deals

April 7, 1999

Protein Activation, Prognosis Link Explored On Breast-Tumor Samples

April 7, 1999

Scotia Failures, Losses Send It Back To Drawing Board

April 7, 1999

BresaGen Begins Phase I Trial Of Anticancer Drug

April 7, 1999

Lorus, Faulding Sign Deal To Develop Cancer Drug

April 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...